Liraglutide was originally approved by the FDA in 2015 as the first GLP-1 agonist for chronic weight management in obese or overweight adults
Common clinical manifestations of malonyl CoA deficiency include psychomotor retardation, seizures, hypotonia, hypertrophic cardiomyopathy, metabolic acidosis, diarrhea, vomiting, and hypoglycemia
EVIDENCE THAT A DEFICIT REDUCES MPS Decreases muscle protein synthesis (MPS) Increases muscle protein breakdown (MPB) Increases protein oxidation ERICS NEW META-REGRESSION ON PROTEIN INTAKE DURING A DEFICIT HUNGER MANAGEMENT STRATEGIES Acceptance based approach Lean into low-energy-density foods Start meals with a salad or soup preload Look for harder-texture, solid food sources over liquids Eat slowly and mindfully Whether youre prepping for the stage, a photoshoot, or just want to understand how to get lean without sacrificing muscle, this episode gives you the tools to do it smarter
2021
8 Novel and Emerging Strategies Systemic Medications Fumaric acid esters
Astaxanthin reduces MMP expressions, suppresses cancer cell migrations, and triggers apoptotic caspases of in vitro and in vivo models in melanoma
